Botulax 200 Units

Opis

Botulax 200 Units is a lyophilized powder containing 200 units of purified botulinum toxin type A complex produced by Hugel Inc., a leading South Korean biopharmaceutical company. It is supplied in a single-use vial and reconstituted with preservative-free 0.9% sodium chloride solution before injection. Botulax works by blocking acetylcholine release at the neuromuscular junction, resulting in precise, temporary muscle relaxation or inhibition of glandular secretion—widely recognized as a high-purity, cost-effective alternative to other botulinum toxins with comparable potency, onset, and duration.

Aesthetic Uses

Botulax 200 Units is approved in many countries for the temporary improvement of moderate to severe:

• Glabellar frown lines
• Lateral canthal lines (crow’s feet)
• Horizontal forehead lines

The 200-unit vial is particularly advantageous for:

• Full-face or multi-area treatments in a single session
• High-volume aesthetic clinics treating multiple patients
• Patients requiring higher total doses (stronger musculature, men, or combination protocols)
• Off-label aesthetic indications such as masseter reduction (jaw slimming), platysmal bands, bunny lines, perioral rhytids, gummy smile, chin dimpling, or hyperhidrosis

Typical cosmetic doses range from 20–100 units per session (depending on areas treated and muscle strength), with onset visible in 3–7 days, peak effect at 10–14 days, and duration generally 3–6 months (comparable to Botox and other major brands in clinical studies and user feedback).

Therapeutic Uses

Botulax is approved or used off-label in various regions for:

• Cervical dystonia (spasmodic torticollis)
• Blepharospasm and hemifacial spasm
• Upper and lower limb spasticity
• Chronic migraine
• Focal hyperhidrosis
• Sialorrhea (excessive drooling)

Therapeutic doses vary widely (often 100–400+ units total), requiring expert anatomical placement and frequently electromyography guidance.

Administration & Handling

• Reconstitute with 2.0–5.0 mL sterile, preservative-free saline (yielding 4–10 U/0.1 mL depending on desired concentration)
• Use within 24 hours when refrigerated (2–8°C)
• Inject via fine-gauge needles (30–33G) or cannulas in aesthetic applications

Safety & Side Effects

Common side effects are mild and transient: injection-site pain, swelling, bruising, headache, eyelid ptosis, dry eyes, or mild flu-like symptoms. Serious but rare risks include distant spread of toxin effects (dysphagia, respiratory distress), allergic reactions, or antibody-mediated resistance with repeated use (comparable to other toxins). Contraindications include hypersensitivity to botulinum toxin or human albumin, active infection at injection site, and certain neuromuscular disorders (myasthenia gravis, Lambert-Eaton syndrome, ALS).

As of 2026, Botulax 200 Units is approved in over 60 countries (including South Korea, Europe, Asia, Latin America, the Middle East, and others) and has gained strong global adoption due to its high purity, reliable potency, competitive pricing, and favorable safety profile. It is not FDA-approved in the United States (where similar products include Botox, Dysport, Xeomin, and Jeuveau), but it is legally and widely used in many regions. Botulax must be administered only by qualified healthcare professionals (dermatologists, plastic surgeons, neurologists, etc.) trained in botulinum toxin injection techniques, with thorough patient assessment, informed consent, and follow-up. Always source genuine Botulax from authorized distributors to ensure authenticity, potency, and safety.